Cleaving through complexity: Pan-serotype fluorimetric assays for the dengue virus proteases

Dengue virus (DENV) is a health threat with global impact. The viral NS2B/NS3 protease is responsible for viral polyprotein processing at a number of cleavage sites. This cleavage is indispensable for establishing productive infection, highlighting the pivotal role of the DENV protease. As such this...

Full description

Saved in:
Bibliographic Details
Main Authors: Macedo, Miguel M. (Author) , Lang, Johannes (Author) , Eckstein, Katharina (Author) , Muffler, Selina L. (Author) , Glanzmann, Leah M. (Author) , Klein, Christian D. (Author) , Leuthold, Mila (Author)
Format: Article (Journal)
Language:English
Published: August 2026
In: SLAS discovery
Year: 2026, Volume: 41, Pages: 1-13
ISSN:2472-5560
DOI:10.1016/j.slasd.2026.100310
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.slasd.2026.100310
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S247255522600016X
Get full text
Author Notes:Miguel M. Macedo, Johannes Lang, Katharina Eckstein, Selina L. Muffler, Leah M. Glanzmann, Christian Klein, Mila-M. Leuthold
Description
Summary:Dengue virus (DENV) is a health threat with global impact. The viral NS2B/NS3 protease is responsible for viral polyprotein processing at a number of cleavage sites. This cleavage is indispensable for establishing productive infection, highlighting the pivotal role of the DENV protease. As such this enzyme is a promising target for the development of antivirals. The absence of a standardized enzymatic assay procedure, using diverse assay conditions and protease constructs, poses a challenge in evaluation of inhibition data. Here, we describe the analysis and comparison of assay parameters for proteases of all four circulating DENV1 to DENV4 serotypes, eventually enabling high-throughput screening (HTS). DENV1-4 proteases were used in the detailed exploration of biochemical assay conditions and a number of FRET substrates as well as AMC-coupled fluorogenic substrates were characterized. The DENV1 protease showed the lowest levels of substrate cleavage, with kcat values several folds below the others (0.03 s-1 vs. 0.4 s-1). This prompted us to design novel substrates based on the 2A/2B and 2B/3 cleavage sites. Enzyme kinetics and inhibition of the DENV1-4 proteases were characterized under two widely applicable assay conditions. The feasibility to use these conditions for HTS was verified in 384-well format. Based on the results, we present two robust assay protocols, suitable to examine activity and inhibition of proteases of all four DENV serotypes in parallel, allowing for HTS. A well-characterized assay procedure can enhance coherence in DENV protease studies, contributing to progress in antiviral research.
Item Description:Online verfügbar 28 April 2026, Version des Artikels 14 May 2026
Gesehen am 30.07.2026
Physical Description:Online Resource
ISSN:2472-5560
DOI:10.1016/j.slasd.2026.100310